Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project

Manish K. Jha, Bruce D. Grannemann, Joseph M. Trombello, E. Will Clark, Sara Levinson Eidelman, Tiffany Lawson, Tracy L. Greer, A. John Rush and Madhukar H. Trivedi
The Annals of Family Medicine July 2019, 17 (4) 326-335; DOI: https://doi.org/10.1370/afm.2418
Manish K. Jha
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce D. Grannemann
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph M. Trombello
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Will Clark
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Levinson Eidelman
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
MPH, MSLOC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiffany Lawson
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
MBA, RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tracy L. Greer
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. John Rush
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madhukar H. Trivedi
Center for Depression Research and Clinical Care, UT Southwestern Medical Center, Dallas, Texas (Jha, Granneman, Trombello, Clark, Eidelman, Greer, Trivedi); Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York (Jha); Duke-National University of Singapore, Singapore (Rush); Department of Psychiatry, Duke Medical School, Durham, North Carolina (Rush); Texas Tech University-Health Sciences Center, Permian Basin, Texas (Rush)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: madhukar.trivedi@utsouthwestern.edu
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Rates of positive screen and diagnosis of depression in primary care patients.

    PHQ-2 = Patient Health Questionnaire 2-item scale.

    Note: PHQ-2 positive was defined as a PHQ-2 score >2. Patients who were diagnosed with either major depressive disorder, adjustment disorder with depression, persistent depressive disorder, or unspecified depressive disorder were grouped as depressed.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Selection of treatment plan for depressed outpatients enrolled for at least 18 weeks of study.

    MBC Pharm = Pharmacotherapy prescribed by the primary care provider using measurement-based care approach.

    Note: Treatment was selected by the primary care providers for depressed patients diagnosed as having either major depressive disorder, adjustment disorder with depression, persistent depressive disorder, or unspecified depressive disorder.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Outcomes of depressed patients treated with pharmacotherapy with any follow-up visits.

    Note: Remission was defined as a score of <5 on the Patient Health Questionnaire 9-item scale.

Tables

  • Figures
  • Additional Files
    • View popup
    Table 1

    Baseline Characteristics of Patients Screened in VitalSign6 Project

    CharacteristicsTotal (n = 25,000), No.PHQ-2 Negative (n = 20,675), No. (%)PHQ-2 Positive (n = 4,325), No. (%)Positive vs Negative Missing Data, No.
    χ2 (df)P Value
    Sex8.98 (1)0.0039,115
     Female11,2669,199 (81.65)2,067 (18.35)
     Male4,6193,864 (83.65)755 (16.35)
    Language229.05 (1)<.0010
     English11,7709,282 (78.86)2,488 (21.14)
     Spanish13,23011,393 (86.11)1,837 (13.89)
    Race149.39 (3)<.00117,942
     African American892631 (70.74)261 (29.26)
     White3,1422,449 (77.94)693 (22.06)
     American Indian or Native Alaskan312228 (73.08)84 (26.92)
     Other2,7122,359 (86.98)353 (13.02)
    Ethnicity115.75 (1)<.00117,724 (70.9)
     Hispanic5,9114,911 (83.08)1,000 (16.92)
     Non-Hispanic1,365960 (70.33)405 (29.67)
    • PHQ-2 = Patient Health Questionnaire 2-item scale; df = degrees of freedom.

    • Notes: PHQ-2 positive was defined as a PHQ-2 score >2.

    • View popup
    Table 2

    Baseline Characteristics of PHQ-2 Positive Patients by Depression Severity (N = 4,235)

    CharacteristicDepression Severity Missing Data, No.
    Minimal (n = 167), No. (%)Mild (n = 971), No. (%)Moderate (n = 1,257), No. (%)Moderately Severe (n = 1,084), No. (%)Severe (n = 846), No. (%)
    Categorical variables
    Sex1,503
     Female69 (3.3)407 (19.7)620 (30.0)538 (26.0)433 (21.0)
     Male41 (5.4)191 (25.3)219 (29.0)170 (22.5)134 (17.8)
    Language0
     English91 (3.7)428 (17.2)682 (27.4)696 (28.0)591 (23.7)
     Spanish76 (4.1)543 (29.6)575 (31.3)388 (21.1)255 (13.9)
    Race2,934
     African American18 (6.9)45 (17.2)71 (27.2)64 (24.5)63 (24.1)
     White18 (2.6)170 (24.5)217 (31.3)161 (23.2)127 (21.1)
     American Indian or Native Alaskan0 (0.0)8 (9.5)19 (22.6)26 (31.0)31 (36.9)
     Other20 (5.7)90 (25.5)108 (30.6)76 (21.5)59 (16.7)
    Ethnicity2,920
     Hispanic30 (3.0)240 (24.0)317 (31.7)227 (22.7)186 (18.6)
     Non-Hispanic16 (4.0)64 (15.8)103 (25.4)110 (27.2)112 (27.7)
    Diagnosis0
     Major depressive disorder2 (0.1)184 (9.8)499 (26.5)628 (33.3)571 (30.3)
     Adjustment disorder with depression1 (0.7)52 (37.7)47 (34.1)24 (17.4)14 (10.1)
     Persistent depressive disorder0 (0.0)11 (18.0)23 (37.7)13 (21.3)14 (23.0)
     Unspecified depressive disorder0 (0.0)84 (24.5)132 (38.5)94 (27.4)33 (9.6)
     No psychiatric disorder82 (19.3)206 (48.6)96 (22.6)29 (6.8)11 (2.6)
     Other psychiatric disorder3 (1.6)36 (19.1)55 (29.1)56 (29.6)39 (20.6)
     No diagnosis selected75 (24.7)65 (21.4)51 (16.8)65 (21.4)48 (15.8)
     Unable to confirm3 (0.3)320 (35.6)329 (36.6)149 (16.6)97 (10.8)
    Currently in treatment1 (1.2)13 (15.5)25 (29.8)26 (31.0)19 (22.6)
    Alcohol screen2,102
     Negative64 (4.0)369 (22.9)465 (28.8)382 (23.6)335 (20.7)
     Positive13 (2.1)95 (15.6)178 (29.3)174 (28.6)148 (24.4)
    Drug use screen2,102
     Negative73 (3.9)428 (22.8)561 (29.9)445 (23.7)371 (19.7)
     Positive4 (1.2)36 (10.4)82 (23.8)111 (32.2)112 (32.4)
    Continuous variablesMean (SD)Mean (SD)Mean (SD)Mean (SD)Mean (SD)
    PHQ-93.43 (0.5)7.29 (1.4)11.99 (1.4)16.9 (1.4)22.65 (2.1)0
    GAD-71.74 (2.8)5.4 (4.1)9.16 (4.6)12.84 (4.8)16.93 (4.1)383
    P-FIBS5.47 (7.1)11.11 (8.9)13.64 (8.9)16.41 (9.3)19.03 (9.3)2,019
    Age41.93 (17.8)40.43 (15.6)41.02 (15.1)41.2 (14.7)41.06 (13.9)0
    • PHQ-2 = Patient Health Questionnaire 2-item; PHQ-9 = Patient Health Questionnaire 9-item; GAD-7 = generalized anxiety disorder 7-item scale; P-FIBS = pain frequency, intensity, and burden scale.

    • Notes: Severity of depression26 was defined using PHQ-9 as minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27). Alcohol32 and drug use33 during the past year were screened with self-report measures.

    • View popup
    Table 3

    Baseline Characteristics by Number of Follow-Up Visits (N = 2,160)

    CharacteristicFollow-Up Visits, No. (%)OverallFollow-Up Visits: 0 vs ≥1Missing Data, No.
    0 (n = 1,123)1 (n = 612)2 (n = 225)≥3 (n = 200)P Valueχ2P Valueχ2
    Categorical variables
    Sex2.89.410.15.70814
     Female524 (50.7)274 (26.5)113 (10.9)123 (11.9)
     Male162 (51.9)91 (29.2)25 (8.0)34 (10.9)
    Language0.98.810.09.760
     English683 (52.3)375 (28.7)130 (9.9)119 (9.1)
     Spanish440 (51.6)237 (27.8)95 (11.1)81 (9.5)
    Race39.68<.00122.73<.0011,471
     African American74 (49.3)46 (30.7)17 (11.3)13 (8.7)
     White168 (45.9)93 (25.4)57 (15.6)48 (13.1)
     American Indian or Native Alaskan20 (58.8)10 (29.4)0 (0.0)4 (11.8)
     Other96 (69.1)33 (23.7)8 (5.8)2 (1.4)
    Ethnicity3.42.330.66.421,436
     Hispanic233 (46.5)123 (24.5)67 (13.4)78 (15.6)
     Non-Hispanic111 (49.8)62 (27.8)23 (10.3)27 (12.1)
    Alcohol screen2.49.480.02.891,080
     Negative423 (53.3)204 (25.7)78 (9.8)89 (11.2)
     Positive151 (52.8)75 (26.2)21 (7.3)39 (13.6)
    Drug screen4.23.243.91.051,080
     Negative478 (51.9)243 (26.4)86 (9.3)114 (12.4)
     Positive96 (60.4)36 (22.6)13 (8.2)14 (8.8)
    Follow-up105.24.00013.81<.060
     MBC Pharm T/t637 (45.5)423 (30.2)177 (12.6)163 (11.6)
     Behavioral T/t142 (63.4)44 (19.6)16 (7.2)22 (9.8)
     Active Surveillance113 (64.9)45 (25.9)9 (5.2)7 (4.0)
     No follow-up27 (84.4)3 (9.4)2 (6.2)0 (0.0)
     External Referral94 (68.1)37 (36.8)4 (2.9)3 (2.2)
     Refused T/t110 (57.3)60 (31.3)17 (8.8)5 (2.6)
    Continuous variablesMean (SD)Mean (SD)Mean (SD)Mean (SD)FP ValueFP Value
    PHQ-915.33 (5.46)15.82 (5.38)16.76 (5.23)17.15 (4.90)9.46<.00125.45<.0010
    GAD-711.93 (5.76)11.98 (5.90)12.74 (5.48)13.7 (5.24)6.15<.00110.73.001142
    P-FIBS16.5 (9.44)15.81 (9.53)17.67 (8.58)14.98 (9.29)1.94.130.37.551,044
    Age41.72 (14.78)43.53 (14.58)43.95 (12.56)42.61 (13.04)2.92.046.12.020
    • T/t = treatment; PHQ-9 = Patient Health Questionnaire 9-item; GAD-7 = generalized anxiety disorder 7 item scale; P-FIBS = pain frequency, intensity, and burden scale.

    • The F statistic is a ratio of variation among the group means to the total variation within the samples and large values of the statistic imply larger differences among the group means.

Additional Files

  • Figures
  • Tables
  • Supplemental Appendix

    Supplemental Appendix

    Files in this Data Supplement:

    • Supplemental data - PDF file
  • The Article in Brief

    A Structured Approach to Detecting and Treating Depression in Primacy Care: VitalSign6 Project

    Madhukar H. Trivedi , and colleagues

    Background Major Depressive Disorder affects 5-10% of adults in the United States every year. This report describes outcomes of an ongoing quality-improvement project in a large US metropolitan area to improve recognition, treatment, and outcomes of depressed patients in sixteen primary care clinics.

    What This Study Found A questionnaire-based management algorithm for major depressive disorder in primary care is feasible to implement, though attrition from treatment is high. Among 25,000 patients in primary care clinics in a large metropolitan area, 4,325 (17%) screened positive for depression with 2,426 having a clinician-diagnosed depressive disorder. Of the 2,160 patients who had 18 weeks of follow-up care, 65% were treated with medication. Remission, defined as a PHQ-9 score of less than 5, was more common in patients who experienced 3 or more follow-up visits. Of those who returned for 3 or more visits, 41.7% achieved remission. However, more than one-half of those diagnosed did not return for any follow-up care.

    Implications

    • The findings of this study suggest that patients suffering from depression can be successfully treated using measurement-based care within the primary care setting, and stronger emphasis on patient education and other approaches to reduce attrition may be needed for patients who fail to return for follow-up care.
  • Visual Abstract

    Files in this Data Supplement:

    • Adobe PDF - 17-4-326.png.pdf
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 17 (4)
The Annals of Family Medicine: 17 (4)
Vol. 17, Issue 4
July/August 2019
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project
Manish K. Jha, Bruce D. Grannemann, Joseph M. Trombello, E. Will Clark, Sara Levinson Eidelman, Tiffany Lawson, Tracy L. Greer, A. John Rush, Madhukar H. Trivedi
The Annals of Family Medicine Jul 2019, 17 (4) 326-335; DOI: 10.1370/afm.2418

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project
Manish K. Jha, Bruce D. Grannemann, Joseph M. Trombello, E. Will Clark, Sara Levinson Eidelman, Tiffany Lawson, Tracy L. Greer, A. John Rush, Madhukar H. Trivedi
The Annals of Family Medicine Jul 2019, 17 (4) 326-335; DOI: 10.1370/afm.2418
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Neighborhood Determinants of Primary Care Access in Virginia
  • Proactive Deprescribing Among Older Adults With Polypharmacy: Barriers and Enablers
  • Artificial Intelligence Tools for Preconception Cardiomyopathy Screening Among Women of Reproductive Age
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Mental health
    • Prevention
  • Person groups:
    • Vulnerable populations
  • Methods:
    • Quantitative methods
  • Other topics:
    • Quality improvement

Keywords

  • primary care issues
  • depression
  • measurement-based care
  • quality improvement
  • health care delivery/HSR
  • quality of care
  • primary health care
  • major depressive disorder
  • antidepressants
  • loss to follow-up

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine